Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mastocytosis × midostaurin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 29 Leukemia 5 Myelodysplastic Syndromes 4 Mastocytosis, Systemic 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm, Residual 2 Leukemia, Mast-Cell 2 Congenital Abnormalities 2 Recurrence 1 Rectal Neoplasms 1 Mastocytosis 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 GATA2 Deficiency 1 Aggression 1

Interventions

masitinib 4 Imatinib Mesylate 2 midostaurin 1 fludarabine phosphate 1 fludarabine 1 avapritinib 1 Whole-Body Irradiation 1 Watchful Waiting 1 Transplantation 1 Tacrolimus 1 Stem Cell Transplantation 1 Single-Cell Gene Expression Analysis 1 Radiotherapy 1 Phlebotomy 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Mass Screening 1 Injections 1 Dasatinib 1 Cyclophosphamide 1 Cromolyn Sodium 1 Cladribine 1 Busulfan 1 AK002 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01920204 2015-01-19

Midostaurin in Indolent Systemic Mastocytosis

University Medical Center Groningen

Phase 2 Unknown

Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡